What is CyberKnife radiosurgery and how does robotic radiation work?
CyberKnife radiosurgery is an advanced, non-invasive robotic radiation treatment designed to deliver ablative radiation doses to tumours anywhere in the body with sub-millimetre precision. Despite the word surgery, the procedure involves no scalpels, incisions or general anaesthesia. Instead, it pairs a compact 6-megavolt linear accelerator with an articulated robotic arm capable of moving through hundreds of angles around the patient. As the arm re-positions itself, it directs pinpoint radiation beams that intersect at the exact three-dimensional coordinates of the tumour, depositing a lethal radiation dose within the target while sparing surrounding healthy organs.
A central advantage of cyberknife radiosurgery is its real-time image guidance and respiratory tracking system. Conventional external radiotherapy often relies on broad treatment margins or rigid immobilisation frames to account for organ motion during breathing. In contrast, CyberKnife continuously images internal bony landmarks or implanted gold seeds called fiducials. When a tumour in the lung or liver shifts during respiration, the robotic arm adjusts its trajectory in real time. Patients exploring overseas care often consider specialized oncology treatments in Turkey as part of their treatment pathway. This guide explains how robotic radiosurgery works, what published evidence demonstrates, comparative international costs, and how to organize care abroad.
CyberKnife Radiosurgery in Turkey: how it works
- 1Send your photos and questions
Free and without obligation: tell us what you want to change and send a few photos — by form or WhatsApp.
- 2Get a written plan and price
A surgeon reviews your case and you receive a personal plan with the price, usually within 24 hours. Compare hospitals; nothing is paid in advance.
- 3Travel, surgery and aftercare
Airport pick-up, examination, surgery and check-ups in Istanbul, then follow-up with your surgeon after you fly home.
- Within about 2 hours
A coordinator replies in your language by WhatsApp or e-mail.
- Within 24 hours
A surgeon reviews your photos and you receive a written plan with the surgeon's name and the price.
- You decide
Ask anything and take your time — nothing is paid in advance.
Why plan CyberKnife Radiosurgery in Turkey with Treat Journey?
- Free for patients
Searching, comparing and requesting quotes costs nothing. You pay the hospital directly, at the price in your written quote — never a pre-payment to us.
- Real hospital prices, published
Every price on this page is the hospital's own price for international patients, shown live in your currency, with what the package includes.
- A named surgeon and a written plan
Your quote names the surgeon and the hospital and lists exactly what is included — no anonymous packages.
- Licensed hospitals only
We list licensed hospitals with an international patient department; accreditations such as JCI are shown on each hospital page.
- Honest reviews
We show real patient reviews, including Google reviews and critical ones, and we never invent ratings.
- Support before, during and after
A coordinator in your language answers within hours, arranges transfers and an interpreter, and stays in touch after you fly home.
Does CyberKnife radiosurgery work: what the clinical evidence shows
Extensive clinical research over two decades shows that stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) delivered with robotic systems achieve high rates of local tumour control. Guidelines from professional bodies, including the European Society for Radiotherapy and Oncology (ESTRO) and the American Society for Radiation Oncology (ASTRO), recognize stereotactic radiation as a standard therapeutic option for early-stage inoperable non-small cell lung cancer, solitary brain metastases and medically complex spinal tumours. In early lung cancer, local control rates regularly exceed 85% to 90%, comparable to surgical wedge resection in selected candidates.
In organ-confined prostate cancer, multi-centre trials demonstrate five-year disease-free survival rates above 90% when using five-fraction stereotactic protocols. Benign intracranial conditions such as vestibular schwannomas (acoustic neuromas) and meningiomas also show tumour control rates exceeding 90% alongside high rates of cranial nerve preservation. For isolated spinal metastases, radiosurgery provides effective pain relief and local tumour stability when surgical decompression is not feasible.
However, clinical evidence also underlines the limitations of cyberknife radiosurgery. It is not a cure for widespread systemic cancer with diffuse metastases, nor can it replace systemic interventions when circulating cancer cells exist. In multimodal cancer care, focal radiation is frequently coordinated alongside systemic therapies or focal modalities like radiofrequency ablation. Furthermore, tumours larger than 4 centimetres rarely suit single- or few-fraction ablative doses due to normal tissue tolerance limits. Responsible cancer centres never promise complete cure or disease eradication.
CyberKnife radiosurgery cost in Turkey compared with the UK, US and Germany
The figures below outline approximate price ranges for a complete course of stereotactic radiosurgery, covering pre-treatment imaging simulation, medical physics dosimetry calculations and all treatment fractions. These represent wide international benchmarks rather than individual hospital quotes. A patient's actual fee depends on anatomical location, the number of lesions and case complexity.
| Country | Approximate cost range |
|---|---|
| Turkey | €4,500 – €9,500 |
| United Kingdom | €14,000 – €28,000 |
| United States | €22,000 – €55,000 |
| Germany | €12,000 – €24,000 |
Several clinical factors determine the final cyberknife radiosurgery cost. Cranial treatments utilizing non-invasive mesh masks generally involve lower preparation expenses than abdominal or thoracic treatments, which often require an interventional radiologist to insert fiducial markers under local anaesthesia. The total number of fractions (typically one to five sessions) and whether multiple separate lesions are targeted in one treatment plan also affect the cyberknife radiosurgery price.
In Turkey, hospital packages commonly include pre-treatment 4D-CT simulation, multidisciplinary tumour board review, medical physics planning, delivery sessions, nursing care and airport-to-clinic transfers. Accommodation arrangements vary by package. Patients can request a formal written price breakdown through a free quote prior to travelling.
CyberKnife, Gamma Knife or conventional radiotherapy?
Patients assessing radiation modalities encounter different technical approaches. Conventional external beam radiotherapy delivers small daily doses over five to seven weeks (25 to 35 fractions). Because conventional linear accelerators use broader safety margins to account for organ motion, surrounding healthy tissue receives more cumulative radiation, which restricts the daily dose. Stereotactic techniques, by contrast, focus high biological doses into five or fewer outpatient appointments.
| Technology | Best suited to | Typical limits |
|---|---|---|
| CyberKnife Radiosurgery | Brain, spine, lung, prostate, liver; moving tumours; frame-free treatment | 1–5 fractions; lesion size ideally under 4 cm; requires tracking setup |
| Gamma Knife | Isolated cranial brain tumours, arteriovenous malformations, trigeminal neuralgia | Brain and upper cervical spine only; traditionally requires rigid pin-fixed head frame |
| Conventional Radiotherapy (EBRT) | Large tumour volumes, regional lymph node fields, widespread disease | Daily treatments over 4–7 weeks; wider margins irradiate more healthy tissue |
When comparing CyberKnife with Gamma Knife, anatomical site is the deciding factor. Gamma Knife focuses strictly on brain lesions and trigeminal neuralgia, traditionally requiring a metallic head frame fixed to the skull with pins under local anaesthesia. CyberKnife delivers frame-free treatment anywhere in the body, utilizing image guidance to track tumour position. Where disease involves extensive lymph node networks, conventional radiotherapy or concurrent chemotherapy remains standard practice.
Which tumours and anatomical sites can CyberKnife treat?
The versatility of the robotic arm allows cyberknife radiosurgery in Turkey to treat lesions throughout the body:
- Brain and skull base: Solitary and multiple brain metastases, meningiomas, acoustic neuromas, pituitary adenomas and vascular malformations.
- Spine: Primary spinal cord tumours and vertebral metastases situated millimeters from nervous tissue that cannot tolerate conventional broad-beam radiation.
- Lung: Early-stage peripheral and central non-small cell lung tumours in patients unsuitable for surgery, as well as isolated metastatic deposits.
- Prostate: Localised prostate cancer, completing radical curative-intent radiation in five sessions instead of weeks of conventional visits.
- Liver and pancreas: Primary hepatocellular carcinoma, solitary liver metastases and non-resectable pancreatic tumours benefiting from respiratory tracking.
- Recurrent tumours: Previously irradiated sites requiring narrow re-irradiation margins to avoid damaged normal tissue.
Who is an appropriate candidate, and who is not?
Determining candidate suitability requires detailed oncological review. Appropriate candidates typically present with well-demarcated primary tumours or oligometastatic disease (generally one to five distinct lesions). The technique is especially valuable for individuals considered medically inoperable due to cardiovascular conditions, poor lung function, older age, or lesions located near critical structures such as the brainstem or spinal cord where surgical resection poses extreme risk.
Conversely, CyberKnife does not suit patients with widespread, diffuse metastatic disease where systemic pharmaceutical treatment is paramount. Lesions larger than four to five centimetres in diameter carry elevated risks of radiation necrosis and severe normal tissue injury under ablative dosing. In addition, patients experiencing severe spinal instability needing mechanical stabilisation, active tumour ulceration into the gastrointestinal tract, or an inability to lie supine for 45 minutes require alternative surgical or palliative care.
The treatment process: planning, fiducials and radiation delivery
The clinical workflow proceeds through three essential phases to guarantee mathematical precision and patient safety:
1. Immobilisation and simulation imaging
The team constructs an individual immobilisation device, such as an open-face thermoplastic mesh mask for brain lesions or a vacuum mattress for body treatments. The patient undergoes high-resolution 4D-CT and contrast MRI scans in this exact treatment position. If treating moving organs like the liver or prostate, an interventional radiologist places tiny gold fiducials several days before scanning.
2. Medical physics calculation and dosimetry
The radiation oncologist and medical physicist contour the tumour volume and surrounding organs at risk on cross-sectional images. Advanced computer software plans beam trajectories, calculating thousands of permutations over two to four days to produce a steep dose fall-off that shields adjacent sensitive tissue.
3. Robotic radiation delivery
The patient rests on the treatment couch while the robotic arm moves quietly around them. Ceiling-mounted X-ray detectors continuously photograph anatomical landmarks, matching beam positions to patient breathing. Each session lasts 30 to 90 minutes. No anaesthesia is needed, and the beam produces no physical sensation.
CyberKnife radiosurgery before and after: what follow-up scans show
Unlike surgical resection where pathological tissue is removed instantly, cyberknife radiosurgery before and after progress unfolds over months. High-dose ionizing radiation damages tumour DNA, preventing malignant cells from dividing. Cellular destruction happens gradually, followed by natural immune clearance of cellular debris.
Follow-up imaging (MRI, CT or PET-CT) scheduled at three, six and twelve months evaluates response using criteria like RECIST. Positive responses appear as stopped growth, reduced contrast uptake, central necrosis or gradual volumetric shrinkage. Patients must understand that temporary swelling (radiation pseudoprogression) commonly appears between two and six months post-treatment, mimicking tumour enlargement before subsiding. Experienced oncologists distinguish pseudoprogression from true progression before altering treatment protocols.
Trip timeline and recovery milestones after stereotactic treatment
Organizing travel to Turkey requires adequate time. Because dosimetry calculations and safety verification require two to four days between simulation imaging and the initial treatment, the recommended stay is 8 to 12 nights. Fractions are usually scheduled every other day (such as Monday, Wednesday and Friday) to allow normal tissues recovery intervals.
Overall cyberknife radiosurgery recovery is much less demanding than post-surgical rehabilitation. Without surgical incisions or blood loss, patients walk out of the clinic following each fraction and can eat normal meals. Mild fatigue is the most frequent symptom, emerging during treatment week and easing over two to three weeks. Sedentary work can often continue during the trip, whereas heavy physical exertion should wait two weeks. Before travelling home, patients attend an exit review with their oncologist to verify wellness and finalize imaging transfer plans.
Potential side effects and complications of radiosurgery
Although stereotactic robotics limit collateral damage, high-dose radiation carries known risks. Established healthcare authorities such as the UK National Health Service (NHS) and radiation oncology societies classify side effects by anatomical region:
- General reactions: Mild to moderate tiredness affects 30% to 50% of patients across all treatment locations.
- Brain and spine: Localised swelling (edema) causing headaches, managed with short courses of oral corticosteroids like dexamethasone. Radiation necrosis occurs in 3% to 7% of brain cases months later.
- Chest and lungs: Mild radiation pneumonitis (inflammatory cough or shortness of breath) occurring one to three months post-treatment, generally responding to anti-inflammatory medication.
- Abdomen and pelvis: Transient nausea, loose stools or temporary urinary frequency during or shortly following pelvic and abdominal sessions.
Secondary radiation-induced cancers are mathematically possible but remain rare due to the steep dose gradient outside the targeted volume.
How to evaluate an international oncology centre and red flags
Selecting an overseas hospital for radiosurgery demands thorough verification. Treatment accuracy depends on the expertise of radiation oncologists, medical physicists, dosimetrists and diagnostic radiologists. Warning signs include clinics offering same-day irradiation without multi-day physics verification, quotes lacking a named radiation oncologist, claims of certain tumour eradication, and facilities without structured post-discharge follow-up pathways.
Key questions to ask the oncology team include:
- Is the hospital accredited by an international body such as Joint Commission International (JCI)?
- Will my treatment plan be reviewed by a formal multidisciplinary tumour board?
- Which generation of CyberKnife technology (such as the M6 or S7 platform) does the department use?
- How many stereotactic radiosurgery procedures does your clinical team perform each year?
- How will your team communicate with my local doctor if I develop delayed swelling or symptoms after returning home?
To understand the coordination pathway, review how our process works and submit your diagnostic records through our free quote service for hospital evaluation.
Frequently asked questions
CyberKnife radiosurgery is a non-invasive treatment that uses a compact linear accelerator mounted on a robotic arm to deliver high-dose, sub-millimetre radiation beams to tumours anywhere in the body. It tracks tumour motion in real time, avoiding the need for surgical incisions, general anaesthesia or rigid metal head frames.
Yes, for defined primary tumours and isolated metastases. Clinical studies document local control rates between 85% and 95% for early-stage lung tumours, brain metastases, prostate cancer and benign intracranial lesions. It destroys tumour DNA so cells stop dividing, but it cannot cure diffuse, widely disseminated metastatic disease.
Approximate treatment costs in Turkey range from €4,500 to €9,500, compared with €14,000 to €28,000 in the UK and higher in the US. The exact price depends on whether fiducials are required, the number of target lesions and the number of delivery fractions. Hospitals provide itemised quotes after reviewing imaging.
Scans do not show tumours vanishing overnight. Cellular breakdown occurs gradually over months. Success appears as halted growth, loss of blood supply and shrinkage on three- and six-month MRI or CT scans. Temporary swelling, known as pseudoprogression, often mimics tumour growth on early scans before settling.
Gamma Knife is specialized exclusively for brain and upper cervical spine conditions and traditionally uses a metal head frame fixed to the skull with pins. CyberKnife treats tumours anywhere in the body—including the lungs, prostate, liver and spine—without a rigid skull frame, tracking movement automatically.
Ideal candidates have discrete, well-defined tumours or oligometastases (one to five lesions) in the brain, spine, lung, liver or prostate. It particularly suits patients who cannot undergo invasive open surgery due to anaesthetic risks, advanced age or tumour proximity to critical structures like the spinal cord.
Because treatment requires no incisions, day-to-day recovery is rapid. Patients leave the hospital immediately after each 30- to 90-minute session and can walk and eat normally. Mild fatigue is common and lasts two to three weeks. Most individuals resume desk work within days and light exercise after two weeks.
The radiation beam produces no physical pain or sensation, similar to a diagnostic X-ray. Patients lie on a cushioned table while the robotic arm moves quietly around them. No general anaesthesia is needed, though mild muscle stiffness can occur from lying still during the 30- to 90-minute delivery session.
Tumour cells destroyed by ablative radiation do not regenerate. In successfully treated lesions, local control is long-lasting. However, radiosurgery only treats targeted areas; it does not prevent new metastases from developing elsewhere in the body, which is why ongoing oncological monitoring remains necessary.
A stay of 8 to 12 nights is typical. This allows time for diagnostic simulation scans, two to four days of medical physics dosimetry calculations, one to five treatment fractions delivered on alternate days, and an exit consultation with the radiation oncology team before flying home.